Jeffrey David Jonker's Net Worth

$281 Thousand

Estimate Recalculated Sep 8, 2024 07:30PM EST

Who is Jeffrey David Jonker?

Jeffrey David Jonker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include THERAVANCE INC, Theravance Biopharma, Inc., and Metacrine, Inc..

SEC CIK

Jeffrey David Jonker's CIK is 0001589394

Past Insider Trading and Trends

2013 was Jeffrey David Jonker's most active year for acquiring shares with 2 total transactions. Jeffrey David Jonker's most active month to acquire stocks was the month of April. 2013 saw Jeffrey David Jonker paying a total of $0.00 for 165,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

THERAVANCE INC (INVA) Snapshot price: $18.7201

Senior VP, Corp. & Bus. Dev.

Jeffrey David Jonker owns 15,000 units of Common Stock which is worth $280,801.50. In the year 2013 Jeffrey David Jonker filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
15K
—
—
15K
Oct 22
Form 3
—
0
—
—
0
No matching records found

Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.01

Senior VP, Corp. & Bus. Dev.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 3
Form 3
—
0
—
—
0
No matching records found

Metacrine, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Mar 17
Form 3
—
0
—
—
0
No matching records found